Immediate Impact
3 standout
Citing Papers
Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19
2022 Standout
Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance
2022 Standout
Works of Anna Solé‐Ribalta being referenced
The different manifestations of COVID-19 in adults and children: a cohort study in an intensive care unit
2021
Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Anna Solé‐Ribalta | 157 | 37 | 43 | 41 | 30 | 229 | |
| Biru Li | 124 | 21 | 44 | 24 | 21 | 235 | |
| Pekka Valmari | 183 | 17 | 54 | 50 | 22 | 284 | |
| Daniel Molano-Franco | 56 | 54 | 80 | 37 | 27 | 293 | |
| Carmel Curtis | 111 | 17 | 19 | 26 | 27 | 286 | |
| Emanuela Biagioni | 101 | 62 | 21 | 28 | 31 | 258 | |
| Alejandro Donoso | 98 | 42 | 133 | 15 | 32 | 286 | |
| Francesco Travaglino | 185 | 47 | 42 | 52 | 22 | 297 | |
| Susana Pissarra | 73 | 14 | 99 | 26 | 41 | 253 | |
| J.-F. Diependaele | 77 | 14 | 100 | 23 | 19 | 232 | |
| Guangzhi Shi | 58 | 57 | 19 | 14 | 29 | 211 |
All Works
Login with ORCID to disown or claim papers
Loading papers...